To include your compound in the COVID-19 Resource Center, submit it here.

Acambis in vaccine deal

Acambis (LSE:ACM; ACAM) closed a deal with Swiss Serum

Read the full 99 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE